Remecure ApS: Financial statements 2023
CVR: 40259724
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Remecure ApS (CVR 40259724) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 298,470 and a net result of DKK 238,485 compared with DKK -38,720 the year before. Equity in the 2023 report amounted to DKK 247,030. The solvency ratio was 17.5%.
- Gross Profit
- DKK 298,470
- Profit/Loss
- DKK 238,485
- Equity
- DKK 247,030
- Total Assets
- DKK 1,408,894
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 298 t. | 238 t. | 247 t. | 0 |
| 2022 | - | -31 t. | -39 t. | 9 t. | 0 |
| 2021 | - | 20 t. | 17 t. | 47 t. | 0 |
| 2020 | - | -295 | -554 | -10 t. | 0 |
| 2019 | - | -9 t. | -9 t. | -9 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Remecure ApS has published its annual report for 2022. Gross profit came to DKK -30,765, and the net result was DKK -38,720.
About Remecure ApS
Remecure ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Stephanie Cecilia Arnfeldt Castella and Mohamed MAMDOUH Takach. The company is owned by Stephanie Cecilia Arnfeldt Castella and Mohamed MAMDOUH Takach. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 8,950 and a net result of DKK 5,453 compared with DKK -17,659 the year before. Equity in the 2025 report amounted to DKK 234,891.